Objective To explore the efficacy of budesonide combined with ambroxol hydrochloride in the treatment of mycoplasma pneumonia in children and the effect on lung function. Methods A total of 90 children with mycoplasma pneumonia admitted to our hospital were selected as the study target and divided into control group (n=44) and study group (n=46) according to random number table method. The study period was from January 2020 to January 2021. The control group received budesonide treatment, while the study group received budesonide combined with ambroxol hydrochloride treatment. The therapeutic effect, pulmonary function index and MP infection recurrence rate of the two groups were studied. Results After treatment, there was no significant difference in lung function indexes between the two groups (P＜0.05). The total effective rate of the study group (97.83％) was higher than that of the control group (81.82％), and the difference was statistically significant (P＜0.05). The recurrence rate of MP infection in the study group (2.17％) was lower than that in the control group (22.72％), and the difference was statistically significant (P＜0.05). Conclusion The combination of budesonide and ambroxol hydrochloride in the treatment of pediatric mycoplasma pneumonia is effective, which can improve lung function indexes and reduce the recurrence rate of MP infection.
budesonideambroxol hydrochloridemycoplasma pneumonia in childrencurative effectlung function
万方数据
